"10.1371_journal.pone.0025565","plos one","2011-09-27T00:00:00Z","Nicolas Deblon; Christelle Veyrat-Durebex; Lucie Bourgoin; Aurélie Caillon; Anne-Lise Bussier; Stefania Petrosino; Fabiana Piscitelli; Jean-Jacques Legros; Vincent Geenen; Michelangelo Foti; Walter Wahli; Vincenzo Di Marzo; Françoise Rohner-Jeanrenaud","Division of Endocrinology, Diabetology and Nutrition, Department of Internal Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Department of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Endocannabinoid Research Group, Institute of Biomolecular Chemistry, CNR, Naples, Italy; Centre Hospitalier Régional de la Citadelle, University of Liege, Liege, Belgium; Centre of Immunology, University of Liege, CHU B-23, Liege, Belgium; Center for Integrative Genomics, National Research Center Frontiers in Genetics, University of Lausanne, Lausanne, Switzerland","Conceived and designed the experiments: ND FRJ. Performed the experiments: ND FRJ CVD LB MF AC ALB SP VDM FP. Analyzed the data: ND. Contributed reagents/materials/analysis tools: JJL WW VG. Wrote the paper: ND FRJ.","The authors have read the journal's policy and have the following conflicts: Patent application N° PCT/IB2011/052156 covering novel therapeutic uses of oxytocin has been filed on 17 May 2011. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2011","09","Nicolas Deblon","ND",13,TRUE,2,10,1,2,TRUE,TRUE,FALSE,0,NA,FALSE
